EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effect of antibody-mediated connective tissue growth factor neutralization on lung edema in ventilator-induced lung injury in rats

Charissa E van den Brom iD, Caitlin Bozic, Chantal A Polet, Annabel Bongers, Anita M Tuip-de Boer, Roselique Ibelings, Joris J T H Roelofs, Nicole P Juffermans

Molecular Medicine · 2024

DOI: 10.1186/s10020-024-00829-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Medicine, 2024. Verfasst von Charissa E van den Brom und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Amsterdam UMC, VU University, Amsterdam, The Netherlands. c.vandenbrom@amsterdamumc.nl. Hauptthemen laut MEDLINE: Ventilator-Induced Lung Injury, Connective Tissue Growth Factor, Pulmonary Edema. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FibroGen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Acute respiratory distress syndrome (ARDS) is characterized by alveolar edema that can progress to septal fibrosis. Mechanical ventilation can augment lung injury, termed ventilator-induced lung injury (VILI). Connective tissue growth factor (CTGF), a mediator of fibrosis, is increased in ARDS patients. Blocking CTGF inhibits fibrosis and possibly vascular leakage. This study investigated whether neutralizing CTGF reduces pulmonary edema in VILI.

Methods

Following LPS administration, rats were mechanically ventilated for 6 h with low (6 mL/kg; low V T ) or moderate (10 mL/kg; mod V T ) tidal volume and treated with a neutralizing CTGF antibody (FG-3154) or placebo lgG (vehicle). Control rats without LPS were ventilated for 6 h with low V T . Lung wet-to-dry weight ratio, FITC-labeled dextran permeability, histopathology, and soluble RAGE were determined.

Results

VILI was characterized by reduced PaO 2 /FiO 2 ratio (low V T : 540 [381–661] vs. control: 693 [620–754], p < 0.05), increased wet-to-dry weight ratio (low V T : 4.8 [4.6–4.9] vs. control: 4.5 [4.4–4.6], p < 0.05), pneumonia (low V T : 30 [0–58] vs. control: 0 [0–0]%, p < 0.05) and interstitial inflammation (low V T : 2 [1–3] vs. control: 1 [0–1], p < 0.05). FG-3154 did not affect wet-to-dry weight ratio (mod V T + FG-3154: 4.8 [4.7–5.0] vs. mod V T + vehicle: 4.8 [4.8–5.0], p > 0.99), extravasated dextrans (mod V T + FG-3154: 0.06 [0.04–0.09] vs. mod V T + vehicle: 0.04 [0.03–0.09] µg/mg tissue, p > 0.99), sRAGE (mod V T + FG-3154: 1865 [1628–2252] vs. mod V T + vehicle: 1885 [1695–2159] pg/mL, p > 0.99) or histopathology. Conclusions ‘Double hit’ VILI was characterized by inflammation, impaired oxygenation, pulmonary edema and histopathological lung injury. Blocking CTGF does not improve oxygenation nor reduce pulmonary edema in rats with VILI. Graphical Abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ventilator-Induced Lung InjuryConnective Tissue Growth FactorPulmonary EdemaAnimalsRatsMaleAntibodies, NeutralizingRats, Sprague-DawleyLungDisease Models, AnimalReceptor for Advanced Glycation End Products

Stichwörter der Autor:innen

ARDSCTGFEdemaLungVentilator-induced lung injury

Substanzen

Connective Tissue Growth FactorAntibodies, NeutralizingReceptor for Advanced Glycation End Products

Autor:innen und Institutionen

  • Department of Anesthesiology, Amsterdam UMC, VU University, Amsterdam, The Netherlands. c.vandenbrom@amsterdamumc.nl.
  • Laboratory for Experimental Intensive Care and Anesthesiology (LEICA), Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands. c.vandenbrom@amsterdamumc.nl.
  • Department of Intensive Care Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands. c.vandenbrom@amsterdamumc.nl.
  • Department of Anesthesiology, Amsterdam UMC, VU University, Amsterdam, The Netherlands.
  • Laboratory for Experimental Intensive Care and Anesthesiology (LEICA), Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Department of Intensive Care Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

ORCID-Profile: Charissa E van den Brom

Förderung

  • FibroGen

Zitieren

APA

van den Brom, C. E., Bozic, C., Polet, C. A., Bongers, A., Tuip-de Boer, A. M., Ibelings, R., Roelofs, J. J. T. H., & Juffermans, N. P. (2024). Effect of antibody-mediated connective tissue growth factor neutralization on lung edema in ventilator-induced lung injury in rats. Molecular Medicine. https://doi.org/10.1186/s10020-024-00829-4

Vancouver

van den Brom CE, Bozic C, Polet CA, Bongers A, Tuip-de Boer AM, Ibelings R, et al. Effect of antibody-mediated connective tissue growth factor neutralization on lung edema in ventilator-induced lung injury in rats. Molecular Medicine. 2024. doi:10.1186/s10020-024-00829-4

BibTeX
@article{vandenBrom2024,
  author = {van den Brom, Charissa E and Bozic, Caitlin and Polet, Chantal A and Bongers, Annabel and Tuip-de Boer, Anita M and Ibelings, Roselique and Roelofs, Joris J T H and Juffermans, Nicole P},
  title = {Effect of antibody-mediated connective tissue growth factor neutralization on lung edema in ventilator-induced lung injury in rats},
  journal = {Molecular Medicine},
  year = {2024},
  doi = {10.1186/s10020-024-00829-4}
}
Kostenlos starten →